Torrent Pharmaceuticals

TORNTPHARM

₹ 3,202.51

₹ 20.37

0.64%

Healthcare

₹ 0.00

(%)1D

Updated: 26 Mar 2025, 03:31:03 pm IST

Stock Score

Open Price

₹ 3,220.17

Prev. Close

₹ 3,182.14

₹ 3,173.19

Day Low

₹ 3,237.36

Day High

₹ 2,664.82

52 Week Low

₹ 3,623.71

52 Week High

Quick Bite

Price To Earnings Ratio 65.44	Sector PE 64.22
PB Ratio 15.81	Sector PB 8.24
EPS 48.94	Dividend Yield 1.08
Today's Volume 113.946 K	5 Day Avg. Volume 251.762 K
PEG Ratio 1.98	Market Cap. ₹ 1,10,000.00 Cr.

About Torrent Pharmaceuticals

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain management, gynecology, and dermatology. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its Anti-diabetic products include Gliclazide 80 mg, Tablets, Gliclazide 30 mg, Tablets, Glimepiride 1, 2, 3, 4 mg, Tablets, and others. Its dermatologic therapy products include Macrotor, Ahaglow S Facewash, Fungicide Lotion, Hairjoy 2%, New Dewsoft Cream, Lookbrite 20GMS, Cortaz NC, Dermanex, and others. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.

Torrent Pharmaceuticals Share Price

Torrent Pharmaceuticals Limited is an Indian pharmaceutical company. The company's field of activity is the research, development, production and marketing of generic medicines. It operates in the therapeutic segments Cardiovascular (CV), Gastrointestinal (GI), Central and Central Nervous System, and Vitamin, Mineral Nutrients (VMN). It is also used in therapeutic areas such as anti-epileptic drugs, diabetes treatment, anti-cancer drugs, anti-acne drugs, corticosteroids and cosmetics. It is complex dosage forms developed for the global market based on oral solids, injections, inhalation technologies, long-term depot injections for ophthalmic, nasal, semi-solids for external use and multiparticulate sustained-release oral systems. The company develops various in-house new chemical entities (NCE) in the areas of metabolic, cardiovascular, gastrointestinal, dermatology and respiratory diseases. It is represented in more than 40 countries.

Torrent Pharmaceuticals FAQs

How to Buy Torrent Pharmaceuticals Share?

To purchase Torrent Pharmaceuticals shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Torrent Pharmaceuticals (ticker symbol: TORNTPHARM) on the trading platform provided by your broker and purchase the shares.

What's Torrent Pharmaceuticals share price today?

The stock price of Torrent Pharmaceuticals as of 31 Mar 2025 is ₹3,202.51

What is the Market Cap of Torrent Pharmaceuticals?

Market capitalisation represents the total market value of a company's outstanding shares. As of 31 Mar 2025, Torrent Pharmaceuticals (ticker symbol: TORNTPHARM) has a market capitalisation of approximately ₹11,00,00,00,00,000.00

What is the PE and PB ratio of Torrent Pharmaceuticals?

Torrent Pharmaceuticals Ltd's price-to-book ratio as of 31 Mar 2025 is 15.81, reflecting the market's valuation compared to its asset value. As of 31 Mar 2025, the trailing twelve months P/E (price-to-earnings) ratio is 65.44, indicating the market values the company at around ₹65.44 for every ₹1 of earnings

What is the 52 Week High and Low of Torrent Pharmaceuticals Share?

Torrent Pharmaceuticals Ltd (TORNTPHARM) hit its 52-week high at ₹3,623.71, and its 52-week low at ₹2,664.82.

Begin your investment journey today

View All Global Indices